Clinical Trials Browser

Phase 2 × Rectal Neoplasms × Calcium Aluminosilicate × Clear all

NCT00748215 2020-12-02

Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan

Phase 2 Completed

100 enrolled 17 charts

Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms